CareFusion CFN

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
    1. New Morningstar Analyst Report for CareFusion Corp

      Stock Reports

      Fri, 23 May 2014

      CareFusion 's long-term growth potential could be dragged ..... will likely remain a modest growth headwind for CareFusion in the near term.While recent acquisitions have complemented CareFusion 's core operations and expanded its geographic

    2. Timing Issues Weigh on CareFusion ’s Profitability, but Fundamentals Remain Intact


      Tue, 6 May 2014

      CareFusion ’s fiscal third-quarter results fell ..... the Pyxis ES system, we still view CareFusion ’s issues as minor near-term challenges ..... flow model or fair value estimate, and CareFusion retains its narrow economic moat, from

    3. CareFusion CFN Q3 2014 Earnings Call Transcript


      Mon, 5 May 2014

      ladies and gentlemen, and welcome to the Third Quarter 2014 CareFusion Corporation's Earnings Conference Call. My name is Denise ..... On today's call, Kieran and Jim are going to discuss CareFusion 's results for the third quarter ended March 31, 2014 as

    4. CareFusion Reports Another Soft Quarter as Fiscal Year-End Results Appear on Track


      Tue, 4 Feb 2014

      CareFusion 's delayed customer transition to the ..... contracts receive equipment installations. CareFusion reported just over 1% revenue growth ..... value estimate or narrow moat rating for CareFusion as we closely watch results in the dispensing

    5. CareFusion Expands Procedural Solutions Segment With Acquisition of Vital Signs


      Mon, 18 Nov 2013

      CareFusion announced that it plans to acquire the ..... million. The deal should strengthen CareFusion ’s vertical integration in its procedural ..... while this addition potentially boosts CareFusion ’s scale, we’re leaving our narrow

    6. CareFusion ’s Growth Slows on Delayed Customer Sales, but Year-End Performance Still on Track


      Fri, 8 Nov 2013

      CareFusion reported a relatively soft quarter as ..... introduction of the new Pyxis ES platform. CareFusion ’s 1% quarterly revenue decline stemmed ..... Drug Administration, which provides CareFusion another competitor mishap opportunity

    7. CareFusion's Management Confirms Interest in Large Acquisition


      Thu, 8 Aug 2013

      CareFusion 's fiscal fourth-quarter results ..... change our $37 fair value estimate. CareFusion 's shares have faced some volatility ..... potential deals. Given our concerns over CareFusion 's limited position in international

    8. Margin Expansion Helps Offset CareFusion's Top-Line Weakness


      Fri, 10 May 2013

      CareFusion 's CFN 2% decline in first-quarter revenue ..... results. Revenue growth of 6% in the CareFusion 's Procedural Solutions segment partially ..... from macroeconomic concerns, we think CareFusion can mostly meet our expectations

    9. FDA Deals Hospira's Device Segment Heavy Blow, Creates Upside for CareFusion


      Thu, 14 Feb 2013

      value estimate on reduced revenue and profit growth. At the same time, we plan to re-evaluate our assumptions for CareFusion CFN , which should benefit from Hospira's device issues. The import ban appears connected to Hospira's 2012 warning

    « Prev12345Next »
    Content Partners